11.BETA.,16.ALPHA.,17,21-TETRAHYDROXY-5,9-(EPOXYBENZYLYLIDENEAMINO)-5.ALPHA.-PREGNANE-3,20-DIONE-16,17-ACETONIDE
UNII 04SU82953H
Substance Identification & Data
This profile provides standardized clinical and technical data for 11.beta.,16.alpha.,17,21-tetrahydroxy-5,9-(epoxybenzylylideneamino)-5.alpha.-pregnane-3,20-dione-16,17-acetonide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 04SU82953H.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 52091-93-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H41NO8 ZHMQFTXBMPGYLB-OAVHCRLQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 11.beta.,16.alpha.,17,21-tetrahydroxy-5,9-(epoxybenzylylideneamino)-5.alpha.-pregnane-3,20-dione-16,17-acetonide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.